Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-02-16 Sale | 2024-02-20 4:46 pm | Scholar Rock Holding Corp | SRRK | Backstrom Jay T. CHIEF EXECUTIVE OFFICER | 11,614 | $15.74 | $182,842 | 352,671 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-12 Option Award | 2024-02-13 7:17 pm | N/A 2034-02-12 | Scholar Rock Holding Corp | SRRK | Backstrom Jay T. CHIEF EXECUTIVE OFFICER | 500,000 | $0 | 650,000 (Direct) | View |
| 2023-02-13 Option Award | 2023-02-15 4:37 pm | N/A 2033-02-13 | Scholar Rock Holding Corp | SRRK | Backstrom Jay T. CHIEF EXECUTIVE OFFICER | 350,000 | $0 | 350,000 (Direct) | View |
| 2022-12-29 Option Award | 2023-01-03 5:05 pm | N/A 2032-12-28 | Disc Medicine Inc. | IRON | Backstrom Jay T. Director | 7,000 | $0 | 7,000 (Direct) | View |
Ownership | 2023-01-03 5:00 pm | N/A 2032-02-06 | Disc Medicine Inc. | IRON | Backstrom Jay T. Director | 0 | $0 | 23,743 (Direct) | View |
| 2022-09-20 Option Award | 2022-09-22 4:16 pm | N/A 2032-09-20 | Scholar Rock Holding Corp | SRRK | Backstrom Jay T. CEO-Elect | 1,000,000 | $0 | 1,000,000 (Direct) | View |
| 2021-11-19 Equity Swap | 2021-11-22 09:04 am | N/A N/A | ACCELERON PHARMA INC | XLRN | Backstrom Jay T. EVP, Research and Development | 21,233 | $0 | 0 (Direct) | View |
| 2021-11-19 Disposition | 2021-11-22 09:04 am | N/A N/A | ACCELERON PHARMA INC | XLRN | Backstrom Jay T. EVP, Research and Development | 117,859 | $0 | 0 (Direct) | View |
| 2021-01-29 Option Award | 2021-02-02 7:15 pm | N/A 2031-01-29 | ACCELERON PHARMA INC | XLRN | Backstrom Jay T. EVP, Research and Development | 26,305 | $0 | 41,677 (Direct) | View |
| 2021-01-04 Tax Withholding | 2021-01-06 7:05 pm | N/A N/A | ACCELERON PHARMA INC | XLRN | Backstrom Jay T. EVP, Research and Development | 1,735 | $124.31 | 15,372 (Direct) | View |
| 2020-01-02 Option Award(A) | 2020-02-10 6:01 pm | N/A 2030-01-02 | ACCELERON PHARMA INC | XLRN | Backstrom Jay T. EVP, Research and Development | 96,963 | $0 | 96,963 (Direct) | View |
| 2020-01-02 Option Award | 2020-01-03 9:32 pm | N/A 2030-01-02 | ACCELERON PHARMA INC | XLRN | Backstrom Jay T. EVP, Research and Development | 111,972 | $0 | 111,972 (Direct) | View |